Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis
Crossref DOI link: https://doi.org/10.1007/s40273-017-0529-x
Published Online: 2017-06-28
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Simoens, Steven
Jacobs, Ira
Popovian, Robert
Isakov, Leah
Shane, Lesley G.
Funding for this research was provided by:
Pfizer
License valid from 2017-06-28